Mirae Asset Global Investments Co. Ltd. Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Mirae Asset Global Investments Co. Ltd. increased its stake in Intuitive Surgical by 7.4% during Q2, owning about 0.06% of the company, valued at $124.9 million.
• Insider Gary S. Guthart sold 29,360 shares for over $13.8 million, reducing his ownership by nearly 60%.
• Analysts have mixed views, with a consensus rating of "Moderate Buy" and an average price target of $594.19, amid price target adjustments this month.

Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 229,842 shares of the medical equipment provider's stock after buying an additional 15,879 shares during the period. Mirae Asset Global Investments Co. Ltd. owned about 0.06% of Intuitive Surgical worth $124,898,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares in the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. TD Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. BTIG Research reaffirmed a "buy" rating and issued a $571.00 price target on shares of Intuitive Surgical in a report on Wednesday. The Goldman Sachs Group reduced their price target on shares of Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating on the stock in a report on Wednesday. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Finally, Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Fourteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $594.19.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $443.01 on Friday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a 50 day moving average price of $464.42 and a 200 day moving average price of $500.22. The firm has a market capitalization of $158.81 billion, a price-to-earnings ratio of 61.79, a price-to-earnings-growth ratio of 4.59 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the business posted $1.78 earnings per share. Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.